Leptin inhibits PPARγ gene expression in hepatic stellate cells in the mouse model of liver damage

Molecular and Cellular Endocrinology

Volumn 323, Issue 2, 2010, Pages 193-200

  Zhou, Yajun ^a   Jia, Xin ^a   Qin, Jianbing ^a   Lu, Cuihua ^b   Zhu, Huixia ^a   Li, Xiangyang ^a   Han, Xiao ^a   Sun, Xiaoliang ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Hepatic stellate cell; Leptin; Peroxisome proliferator activated receptor

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HORMONE ACTION; IN VIVO STUDY; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENETICS; LIVER DISEASE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; LEPTIN; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PPAR GAMMA; RANDOM ALLOCATION; RATS; RECEPTORS, LEPTIN;

EID: 77952955100     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.03.005     Document Type: Article

References (45)

1. Aleffi S., Petrai I., Bertolani C., Parola M., Colombatto S., Novo E., Vizzutti F., Anania F.A., Milani S., Rombouts K., Laffi G., Pinzani M., Marra F. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005, 42:1339-1348.
2. Cao Q., Mak K.M., Lieber C.S. Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J. Cell. Biochem. 2006, 97:188-197.
3. Cao Q., Mak K.M., Ren C., Lieber C.S. Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways. J. Biol. Chem. 2004, 279:4292-4304.
4. Cassiman D., van Pelt J., De Vos R., Van Lommel F., Desmet V., Yap S.H., Roskams T. Synaptophysin: a novel marker for human and rat hepatic stellate cells. Am. J. Pathol. 1999, 155:1831-1839.
5. Clemons A.P., Holstein D.M., Galli A., Saunders C. Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059. Pancreas 2002, 25:251-259.
6. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., Caro J.F. Serum immunoreactive-leptin concentrations in normal weight and obese humans. N. Engl. J. Med. 1996, 334:292-295.
7. Ding X., Saxena N.K., Lin S., Xu A., Srinivasan S., Anania F.A. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am. J. Pathol. 2005, 166:1655-1669.
8. Elinav E., Ali M., Bruck R., Brazowski E., Phillips A., Shapira Y., Katz M., Solomon G., Halpern Z., Gertler A. Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function. Hepatology 2009, 49:278-286.
9. Faggioni R., Feingold K.R., Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001, 15:2565-2571.
10. Galli A., Crabb D.W., Ceni E., Salzano R., Mello T., Svegliati-Baroni G., Ridolfi F., Trozzi L., Surrenti C., Casini A. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002, 122:1924-1940.
11. Han Y.P., Zhou L., Wang J., Xiong S., Garner W.L., French S.W., Tsukamoto H. Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J. Biol. Chem. 2004, 279:4820-4828.
12. Harada K., Isse K., Kamihira T., Shimoda S., Nakanuma Y. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 2005, 41:1329-1338.
13. Hazra S., Xiong S., Wang J., Rippe R.A., Krishna V., Chatterjee K., Tsukamoto H. Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells. J. Biol. Chem. 2004, 279:11392-11401.
14. Honda H., Ikejima K., Hirose M., Yoshikawa M., Lang T., Enomoto N., Kitamura T., Takei Y., Sato N. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 2002, 36:12-21.
15. Ikejima K., Honda H., Yoshikawa M., Hirose M., Kitamura T., Takei Y., Sato N. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001, 34:288-297.
16. Ikejima K., Takei Y., Honda H., Hirose M., Yoshikawa M., Zhang Y.J., Lang T., Fukuda T., Yamashina S., Kitamura T., Sato N. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002, 122:1399-1410.
17. Kawada N., Ikeda K., Seki S., Kuroki T. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. J. Hepatol. 1999, 30:1057-1064.
18. Leclercq I.A., Farrell G.C., Schriemer R., Robertson G.R. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol. 2002, 37:206-213.
19. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ). J. Biol. Chem. 1995, 270:12953-12956.
20. Marra F., Efsen E., Romanelli R.G., Caligiuri A., Pastacaldi S., Batignani G., Gentilini P. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000, 119:466-478.
21. McCullough A.J., Falck-Ytter Y. Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 1999, 29:1328-1329.
22. McCullough A.J., Bugianesi E., Marchesini G., Kalhan S.C. Gender-dependent alterations in serum leptin levels in alcoholic cirrhosis. Gastroenterology 1998, 115:947-953.
23. Memon R.A., Tecott L.H., Nonogaki K., Beigneux A., Moser A.H., Grunfeld C., Feingold K.R. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 2000, 141:4021-4031.
24. Miyahara T., Schrum L., Rippe R., Xiong S., Yee H.F., Motomura K., Anania F.A., Willson T.M., Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 2000, 275:35715-35722.
25. Nakamura T., Nagasaka S., Ishikawa S., Kusaka I., Hayashi H., Saito T., Higashiyama M., Saito T. Clinical implication of serial leptin measurement in subjects with type 2 diabetes mellitus. Endocr. J. 2001, 48:87-94.
26. Potter J.J., Womack L., Mezey E., Anania F.A. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem. Biophys. Res. Commun. 1998, 244:178-182.
27. Qamar A., Sheikh S.Z., Masud A., Jhandier M.N., Inayat I.B., Hakim W., Mehal W.Z. In vitro and in vivo protection of stellate cells from apoptosis by leptin. Dig. Dis. Sci. 2006, 51:1697-1705.
28. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., Khalil L., Turpin G., Opolon P., Poynard T. Liver fibrosis in overweight patients. Gastroenterology 2000, 118:1117-1123.
29. Rhee S.D., Sung Y.Y., Jung W.H., Cheon H.G. Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes. Mol. Cell. Endocrinol. 2008, 294:61-69.
30. Sahai A., Malladi P., Pan X., Paul R., Melin-Aldana H., Green R.M., Whitington P.F. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G1035-1043.
31. Saxena N.K., Ikeda K., Rockey D.C., Friedman S.L., Anania F.A. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002, 35:762-771.
32. Saxena N.K., Titus M.A., Ding X., Floyd J., Srinivasan S., Sitaraman S.V., Anania F.A. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J. 2004, 18:1612-1614.
33. Schoonjans K., Martin G., Staels B., Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol. 1997, 8:159-166.
34. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
35. She H., Xiong S., Hazra S., Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 2005, 280:4959-4967.
36. Tamaoki J., Tagaya E., Kawatani K., Nakata J., Endo Y., Nagai A. Airway mucosal thickening and bronchial hyperresponsiveness induced by inhaled beta 2-agonist in mice. Chest 2004, 126:205-212.
37. Tang Y., Zheng S., Chen A. Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology 2009, 150:3011-3020.
38. Tsukamoto H. Adipogenic phenotype of hepatic stellate cells. Alcohol. Clin. Exp. Res. 2005, 29:132S-133S.
39. Uygun A., Kadayifci A., Yesilova Z., Erdil A., Yaman H., Saka M., Deveci M.S., Bagci S., Gulsen M., Karaeren N., Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 2000, 95:3584-3589.
40. Van der Poorten D., George J. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clin. Liver Dis. 2008, 12:805-824. ix.
41. Wang W., Poole B., Mitra A., Falk S., Fantuzzi G., Lucia S., Schrier R. Role of leptin deficiency in early acute renal failure during endotoxemia in ob/ob mice. J. Am. Soc. Nephrol. 2004, 15:645-649.
42. Zhou Y., Jia X., Wang G., Wang X., Liu J. PI-3K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells. Mol. Cell. Biochem. 2009, 325:131-139.
43. Zhou Y., Jia X., Zhou M., Liu J. Egr-1 is involved in the inhibitory effect of leptin on PPARgamma expression in hepatic stellate cell in vitro. Life Sci. 2009, 84:544-551.
44. Zhou Y., Zheng S., Lin J., Zhang Q.J., Chen A. The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab. Invest. 2007, 87:488-498.
45. Zhou Y.T., Wang Z.W., Higa M., Newgard C.B., Unger R.H. Reversing adipocyte differentiation: implications for treatment of obesity. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2391-2395.